Cambrex (Snapdragon Chemistry)

Global CDMO with specialized peptide capabilities through Snapdragon Chemistry acquisition. Waltham, MA facility offers custom peptide synthesis using SPPS and innovative LPPS (liquid phase peptide synthesis) technology that reduces solvent demand. Expanded in 2025 with new cGMP manufacturing suite including ISO-7 cleanroom for prep HPLC and lyophilization. Part of Cambrex's broader network of 2,000+ experts across North America and Europe.

Cambrex (Snapdragon Chemistry) is listed as a CDMO in the peptide supply chain, serving North America markets from USA (Waltham, MA). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 2 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.